These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10674013)

  • 1. TP53 gene mutation status in pretreatment biopsies of oesophageal adenocarcinoma has no prognostic value.
    Soontrapornchai P; Elsaleh H; Joseph D; Hamdorf JM; House AK; Iacopetta B
    Eur J Cancer; 1999 Nov; 35(12):1683-7. PubMed ID: 10674013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
    Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
    Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 mutations in malignant and premalignant Barrett's esophagus.
    Dolan K; Walker SJ; Gosney J; Field JK; Sutton R
    Dis Esophagus; 2003; 16(2):83-9. PubMed ID: 12823203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
    Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
    Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: a prospective clinico-pathological study and survival analysis of 70 patients.
    Lam KY; Tsao SW; Zhang D; Law S; He D; Ma L; Wong J
    Int J Cancer; 1997 Apr; 74(2):212-9. PubMed ID: 9133458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 gene mutations are rare in nondysplastic Barrett's esophagus.
    Novotna K; Trkova M; Pazdro A; Smejkal M; Soukupova A; Kodetova D; Smejkal P; Sedlacek Z
    Dig Dis Sci; 2006 Jan; 51(1):110-3. PubMed ID: 16416221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis.
    Fisher OM; Lord SJ; Falkenback D; Clemons NJ; Eslick GD; Lord RV
    Gut; 2017 Mar; 66(3):399-410. PubMed ID: 26733670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.
    Berns EM; van Staveren IL; Look MP; Smid M; Klijn JG; Foekens JA
    Br J Cancer; 1998 Apr; 77(7):1130-6. PubMed ID: 9569050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of p53 mutations in oesophageal adenocarcinoma: final results of a 15-year prospective study.
    Madani K; Zhao R; Lim HJ; Casson AG
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1427-32. PubMed ID: 20227286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations.
    Coggi G; Bosari S; Roncalli M; Graziani D; Bossi P; Viale G; Buffa R; Ferrero S; Piazza M; Blandamura S; Segalin A; Bonavina L; Peracchia A
    Cancer; 1997 Feb; 79(3):425-32. PubMed ID: 9028350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.
    Kandioler D; Schoppmann SF; Zwrtek R; Kappel S; Wolf B; Mittlböck M; Kührer I; Hejna M; Pluschnig U; Ba-Ssalamah A; Wrba F; Zacherl J
    J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2280-6. PubMed ID: 25135238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer.
    Casson AG; Manolopoulos B; Troster M; Kerkvliet N; O'Malley F; Inculet R; Finley R; Roth JA
    Am J Surg; 1994 Jan; 167(1):52-7. PubMed ID: 8311140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of the TP53 gene in Barrett's adenocarcinoma.
    Audrézet MP; Robaszkiewicz M; Mercier B; Nousbaum JB; Hardy E; Bail JP; Volant A; Lozac'h P; Gouérou H; Férec C
    Hum Mutat; 1996; 7(2):109-13. PubMed ID: 8829627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of p53 in Barrett's oesophagus.
    Krishnadath KK; van Blankenstein M; Tilanus HW
    Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):81-4. PubMed ID: 7866817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation.
    Soong R; Powell B; Elsaleh H; Gnanasampanthan G; Smith DR; Goh HS; Joseph D; Iacopetta B
    Eur J Cancer; 2000 Oct; 36(16):2053-60. PubMed ID: 11044641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV Status and Mutation Analysis Using Multiparallel Sequencing in Distal Oesophageal and Gastro-oesophageal Junction Adenocarcinomas.
    Vošmik M; Vošmiková H; Sieglová K; Sirák I; Laco J; Ryška A; Petera J; Melichar B; Soumarová R
    Folia Biol (Praha); 2018; 64(2):41-45. PubMed ID: 30338755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of the p53 mutation in esophageal cancer.
    Uchino S; Saito T; Inomata M; Osawa N; Chikuba K; Etoh K; Kobayashi M
    Jpn J Clin Oncol; 1996 Oct; 26(5):287-92. PubMed ID: 8895666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.
    Soslow RA; Altorki NK; Yang G; Xie D; Yang CS
    Mod Pathol; 1999 Jun; 12(6):580-6. PubMed ID: 10392633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma.
    Kosaka T; Yatabe Y; Onozato R; Kuwano H; Mitsudomi T
    J Thorac Oncol; 2009 Jan; 4(1):22-9. PubMed ID: 19096302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.